{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:41:19Z","timestamp":1792370479483,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007339","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000}}],"reference-count":59,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007339.pub2","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T14:50:16Z","timestamp":1256136616000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pentoxifylline for alcoholic hepatitis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Kate","family":"Whitfield","sequence":"first","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rambaldi","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Wetterslev","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD007339.pub2-BIB0001|cit1","first-page":"250A","article-title":"Improved short-term survival with pentoxifylline treatment in severe acute alcoholic hepatitis","volume":"26","author":"Akriviadis","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD007339.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD007339.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1572-0241.2001.03810.x","article-title":"A toast to pentoxifylline","volume":"96","author":"Karnam","year":"2001","journal-title":"The American Journal of Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD007339.pub2-BIB0004|cit4","first-page":"249A","article-title":"Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo-controlled, double-blind trial","volume":"46","author":"Lebrec","year":"2007","journal-title":"Hepatology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD007339.pub2-BIB0005|cit5","first-page":"96A","article-title":"Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis","volume":"14","author":"McHutchison","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0006|cit6","first-page":"A459","article-title":"Role of pentoxifylline in treatment of severe acute alcoholic hepatitis - a randomized controlled trial","volume":"21","author":"Paladugu","year":"2006","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4 (Suppl 1)","key":"10.1002\/14651858.CD007339.pub2-BIB0007|cit7","first-page":"373A","article-title":"Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial","volume":"44","author":"Sidhu","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2036.2003.01809.x","article-title":"A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis","volume":"19","author":"Austin","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD007339.pub2-BIB0009|cit9","first-page":"333","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"14","author":"Cholongitas","year":"2001","journal-title":"Annals of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD007339.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4321\/S1130-01082008000800007","article-title":"Effect of pentoxifylline on survival, cardiac function and both portal and systemic hemodynamics in advanced alcoholic cirrhosis: a randomized double-blind placebo-controlled trial","volume":"100","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2008","journal-title":"Revista Espa\u00f1ola de Enfermedades Digestivas"},{"issue":"4 (Suppl 1)","key":"10.1002\/14651858.CD007339.pub2-BIB0011|cit11","first-page":"654A","article-title":"A randomized controlled double blind study of pentoxifylline in patients with non alcoholic steatohepatitis (NASH)","volume":"44","author":"Lee","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"4 (Suppl 1)","key":"10.1002\/14651858.CD007339.pub2-BIB0013|cit13","first-page":"754A","article-title":"Evaluation of pentoxifylline in patients with severe alcoholic hepatitis non-responders to corticosteriods: a pilot controlled study","volume":"42","author":"Louvet","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD007339.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10620-006-9099-z","article-title":"Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events","volume":"51","author":"Verma","year":"2006","journal-title":"Digestive Diseases and Sciences"},{"issue":"S2","key":"10.1002\/14651858.CD007339.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0168-8278(08)60983-6","article-title":"When corticosteroids fail: rescue treatment with pentoxifylline for alcoholic hepatitis","volume":"48","author":"Watson","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0016|cit16","unstructured":"Pentoxifylline for acute alcoholic hepatitis http:\/\/ClinicalTrials.gov\/show\/NCT00205049"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0017|cit17","unstructured":"Adipose tissue involvement in alcohol-induced liver inflammation in human: study of pro- and anti-inflammatory cytokines and adipokines http:\/\/ClincalTrials.gov\/show\/NCT00388323"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"199","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0019|cit19","first-page":"219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ (Clinical Research Ed)"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"8","key":"10.1002\/14651858.CD007339.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses maybe inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data inapparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.mcg.0000225570.04773.5d","article-title":"Acute alcoholic hepatitis","volume":"40","author":"Ceccanti","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD007339.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0027|cit27","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2307\/2340521","article-title":"On the interpretation of \u03c72 from contingency tables, and the calculation of P","volume":"85","author":"Fisher","year":"1922","journal-title":"Journal of the Royal Statistical Society"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0029|cit29","unstructured":"Gluud C Alcoholic hepatitis: no glucocorticosteroids? FALK Symposium 121. Steatohepatitis (NASH and ASH) 2001 400"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0030|cit30","unstructured":"Gluud C Nikolova D Klingenberg SL Whitfield K Alexakis N Als-Nielsen B Cochrane Hepato-Biliary Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2009, Issue 3. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM196607142750201","article-title":"Prognosis in acute liver disease of alcoholic patients","volume":"275","author":"Hardison","year":"1966","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0034|cit34","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use Guideline for Good Clinical Practice. E6 (R1) ICH Harmonised Tripartite Guideline 1996"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Imperiale","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaerdard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4 (Suppl 1)","key":"10.1002\/14651858.CD007339.pub2-BIB0037|cit37","first-page":"249A","article-title":"Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo-controlled, double-blind trial","volume":"46","author":"Lebrec","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD007339.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2004-832937","article-title":"Diagnosis and therapy of alcoholic liver disease","volume":"24","author":"Levistsky","year":"2004","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"The New England Journal of Meidicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0041|cit41","first-page":"391","article-title":"Recent developments in the treatment of alcoholic hepatitis","volume":"96","author":"Madhotra","year":"2003","journal-title":"Oxford Journal of Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD007339.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"The American Journal of Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD007339.pub2-BIB0044|cit44","first-page":"96A","article-title":"Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis","volume":"14","author":"McHutchison","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0046|cit46","unstructured":"Patient.uk Pentoxifylline http:\/\/www.patient.co.uk\/showdoc\/30003859\/"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0047|cit47","first-page":"234A","article-title":"Corticosteroid therapy reduces mortality from alcoholic hepatitis in patients without encephalopathy. A meta-analysis of randomized trials (RCTs) including French trials","volume":"14","author":"Poynard","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511","article-title":"Glucocorticosteroids for alcoholic hepatitis","author":"Rambaldi","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0049|cit49","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.3748\/wjg.v12.i43.6909","article-title":"Current concepts and controversies in the treatment of alcoholic hepatitis","volume":"12","author":"Rongey","year":"2006","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD007339.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"5","key":"10.1002\/14651858.CD007339.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schultz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0054|cit54","first-page":"373A","article-title":"Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial","volume":"44 Suppl 4","author":"Sidhu","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","article-title":"Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline","volume":"155","author":"Strieter","year":"1988","journal-title":"Biochemical and biophysical research communications"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1\u201325","DOI":"10.2307\/2331554","article-title":"The probable error of a mean","volume":"6","author":"Student","year":"1908","journal-title":"Biometrika"},{"key":"10.1002\/14651858.CD007339.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"276\u201386","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD007339.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7644","key":"10.1002\/14651858.CD007339.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007339.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:08:17Z","timestamp":1792368497000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007339.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007339.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,7]]}}}